17
Growth Score in past quarter
pts
Heat Score 17 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1221171
Bearpac Medical offers the Passio™ system for managing Malignant Pleural Effusions.
- Ted Karwoski: Principal & Founder
About the Company
Bearpac Medical develops medical devices aimed at improving care for patients with malignant pleural effusion (MPE) and malignant ascites. Its primary product, the Passio Pump Drainage System, includes a catheter, a handheld control unit, and a disposable collection kit. This system enables patients to manage fluid drainage at home with
electronically controlled vacuum pressures between -45 and -70 cm H₂O, which is lower than traditional vacuum bottle technologies. The Passio system received FDA 510(k) clearance for treating recurrent pleural effusions and malignant ascites. Additionally, Bearpac Medical has initiated the AESOP clinical trial to assess the safety and efficacy of the Passio system compared to existing catheter systems.